Philips Appoints Jean Botti as Chief Innovation and Strategy Officer

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) today announced the appointment of Jean Botti as Chief Innovation and Strategy Officer as part of the company's strategy to capture a larger portion of the HealthTech opportunities. Jean Botti, who will join Philips as of April 1, 2016 from Airbus Group (AIR), will become a member of Philips' Executive Committee and will report directly to Philips CEO Frans van Houten. Jean Botti will succeed Jim Andrew, who left Philips in the fourth quarter of 2015 for personal reasons.

"I am very pleased that Jean Botti has decided to join Philips on our journey to extending our leadership in health technology, capitalizing on opportunities arising from the consumerization and industrialization of healthcare to transform the delivery of care," said Frans van Houten. "Jean has had a remarkable and distinguished career and his achievements at Airbus are impressive, ranging from his ability to continually improve the company’s innovation capabilities and building intelligent systems, to embedding quality across the company’s value chain. His track record in driving innovation and change in high-tech industries will prove extremely valuable for Philips."

Jean Botti (French, 1957) joins Philips from Airbus Group, a global leader in aeronautics, space and related services, where he served as Chief Technical Officer since 2006. Prior to this, he worked in various roles in Europe and the U.S. at among others Renault and General Motors. He graduated from the National Institute of Applied Sciences (INSA) in Toulouse in 1986, with a degree in mechanical engineering. He holds a PhD in mechanical engineering from the Conservatoire des Arts et Métiers in collaboration with the University of Michigan. Jean Botti also earned an MBA from Central Michigan University and a degree in Research and Development Management from the Massachusetts Institute of Technology (MIT).

"I am excited to join a company that has made it its mission to improve the lives of billions of people every year globally and that has such a strong track record in innovation, advanced technologies and design capabilities," said Jean Botti. "I am convinced that my experience in the automotive and aviation industries in terms of digital transformation and process optimization will support Philips' ambitions to drive the personalization and industrialization of care."

The appointment of Jean Botti is the latest example of Philips' efforts to align its organization in order to better capitalize on HealthTech market opportunities.

Recently, and in addition to his role as CEO of Personal Health, Philips appointed Pieter Nota to the newly-created position of Chief Marketing Officer, whose role is to establish an integrated approach to marketing, building out Philips’ capabilities to drive marketing excellence in the rapidly changing world of health technology.

Furthermore, Philips established the Monitoring, Informatics & Connected Care segment, led by Jeroen Tas and comprising Patient Care & Monitoring Solutions, Healthcare Informatics, Emerging Businesses and a newly created Population Health Management business.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 104,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...